Kenvue (KVUE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Werte in diesem Artikel
Kenvue (KVUE) reported $3.84 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 4%. EPS of $0.29 for the same period compares to $0.32 a year ago.The reported revenue represents a surprise of -0.51% over the Zacks Consensus Estimate of $3.86 billion. With the consensus EPS estimate being $0.28, the EPS surprise was +3.57%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Kenvue performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Sales- Self Care: $1.56 billion versus the two-analyst average estimate of $1.6 billion. The reported number represents a year-over-year change of -4.9%.Net Sales- Essential Health: $1.23 billion versus $1.23 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -2.9% change.Net Sales- Skin Health and Beauty: $1.06 billion versus the two-analyst average estimate of $1.04 billion. The reported number represents a year-over-year change of -4%.View all Key Company Metrics for Kenvue here>>>Shares of Kenvue have returned +3.3% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Kenvue Inc. (KVUE): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Kenvue
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Kenvue
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Kenvue
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu Kenvue
Keine Analysen gefunden.